Nanocarriers Enhance Doxorubicin Uptake in Drug-Resistant Ovarian Cancer Cells
文献类型：期刊论文
| 作者 | Tatjana ; Hans C Arora1, Mark P Jensen2, Ye Yuan1, Aiguo Wu3, Stefan Vogt4, Tatjana Paunesku1,5,* and Gayle E Woloschak1,5 |
| 刊名 | Cancer Research
 |
| 出版日期 | 2012-02-27 |
| 期号 | 72页码:769—778 |
| 通讯作者 | Tatjana |
| 合作状况 | 李雨桐 |
| 中文摘要 | Resistance to anthracyclines and other chemotherapeutics due to P-glycoprotein (PGP)-mediated export is a frequent problem in cancer treatment. Here we report that iron oxide-titanium dioxide core-shell nanocomposites can serve as efficient carriers for doxorubicin to overcome this common mechanism of drug resistance in cancer cells.Doxorubicin nanocarriers (DNCs) increased effective drug uptake in drug-resistant ovarian cells. Mechanistically, doxorubicin bound to the TiO2 surface by a labile bond that was severed upon acidification within cell endosomes. Upon its release doxorubicin traversed the intracellular milieu and entered the cell nucleus by a route that evaded PGP-mediated drug export. Confocal and x-ray fluorescence microscopy with flow cytometry were used to demonstrate the ability of DNC to modulate transferrin uptake and distribution in cells. Increased transferrin uptake occurred through clathrin-mediated endocytosis, indicating that nanocomposites and DNCs may both interfere with removal of transferrin from cells. Together, our findings show that DNCs not only provide an alternative route of delivery of doxorubicin to PGP-over-expressing cancer cells, but may also boost the uptake of transferrin-tagged therapeutic agents. |
| 学科主题 | 材料科学 |
| 原文出处 | EI收录 |
| 公开日期 | 2013-12-16 |
| 源URL | [http://ir.nimte.ac.cn/handle/174433/9564]  |
| 专题 | 宁波材料技术与工程研究所_宁波所知识产出 |
| 推荐引用方式 GB/T 7714 | Tatjana,Hans C Arora1, Mark P Jensen2, Ye Yuan1, Aiguo Wu3, Stefan Vogt4, Tatjana Paunesku1,5,* and Gayle E Woloschak1,5. Nanocarriers Enhance Doxorubicin Uptake in Drug-Resistant Ovarian Cancer Cells[J]. Cancer Research,2012(72):769—778. |
| APA | Tatjana,&Hans C Arora1, Mark P Jensen2, Ye Yuan1, Aiguo Wu3, Stefan Vogt4, Tatjana Paunesku1,5,* and Gayle E Woloschak1,5.(2012).Nanocarriers Enhance Doxorubicin Uptake in Drug-Resistant Ovarian Cancer Cells.Cancer Research(72),769—778. |
| MLA | Tatjana,et al."Nanocarriers Enhance Doxorubicin Uptake in Drug-Resistant Ovarian Cancer Cells".Cancer Research .72(2012):769—778. |
入库方式： OAI收割
来源：宁波材料技术与工程研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。